SCHEMBL9050356

SCHEMBL9050356

Fc1ccc(F)c(-c2cc(-c3ccc(Cl)cc3)n[nH]2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.60
TP53 P04637 1/20 0.60
KMT2A Q03164 9/20 0.57
MEN1 O00255 8/20 0.57
NPC1 O15118 8/20 0.57
RAB9A P51151 7/20 0.57
NPSR1 Q6W5P4 4/20 0.55
HPGD P15428 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
LMNA P02545 2/20 0.55
MCL1 Q07820 2/20 0.55
HTT P42858 1/20 0.55
ALOX15 P16050 4/20 0.52
MAPK1 P28482 2/20 0.52
USP2 O75604 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9049417 0.90 MAPT (0.59) MAPTTP53KMT2AMEN1NPC1
SCHEMBL9047596 0.84 MAPT (0.66) MAPTTP53KMT2AMEN1NPC1
SCHEMBL9049682 0.84 MAPT (0.66) MAPTTP53KMT2AMEN1NPC1
SCHEMBL9051722 0.81 MAPT (0.49) MAPTTP53KMT2AMEN1NPC1
SCHEMBL9048168 0.80 KMT2A (0.56) MAPTTP53KMT2AMEN1NPC1
SCHEMBL22415356 0.77 KMT2A (0.56) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL15425060 0.77 MAPT (0.69) MAPTTP53KMT2AMEN1NPC1
SCHEMBL26467066 0.77 MELK (0.63) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL31660395 0.77 MELK (0.63) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL9049410 0.77 KMT2A (0.55) MAPTTP53KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731796-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 EP disclosed
WO-1995015318-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed